Literature DB >> 8675684

Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein.

G Murugesan1, P L Fox.   

Abstract

Endothelial cell (EC) movement is required for the development and repair of blood vessels. We have previously shown that LDL oxidized by transition metals almost completely suppressed the wound-healing migratory response of vascular EC in vitro. We now report that lysophosphatidylcholine (lysoPC), a lipid component of oxidized LDL, has an important role in the antimigratory activity of the lipoprotein. Purified 1-palmitoyl lysoPC inhibited movement with a half-maximal activity at 12-15 micrometers, and near complete inhibition at 20 micrometers; the inhibitory concentration of lysoPC was consistent with its abundance in oxidized LDL. The inhibition was not due to cytotoxicity since protein synthesis was unaffected and since EC movement was restored after removal of lysoPC. Lysophospholipid activity was dependent on lipid structure. LysoPC's containing 1-position C16 or C18 saturated fatty acids were antimigratory, but those containing C < or = 14 saturated fatty acids or polyunsaturated fatty acids were not. The activity of 1-palmitoyl lysolipids with various head groups was examined. Lysophosphatidylinositol was more antimigratory than lysophosphatidylglycerol and lysophosphatidylcholine, which were more potent than lysophosphatidylserine and lysophosphatidylethanolamine. Monoglyceride was inactive while lysophosphatidate had promigratory activity. These results are consistent with head group size rather than charge as a critical determinant of activity. To show that lysophospholipids within an intact lipoprotein were active, LDL was treated with bee venom phospholipase A2 (PLA2). The modified lipoprotein inhibited EC movement to the same extent as iron-oxidized LDL and antimigratory activity correlated with the amount of lysoPC formed. To determine antimigratory activity of lysoPC present in oxidized LDL, lipid extracts from oxidized LDL were fractionated by normal phase HPLC. The fraction comigrating with lysoPC had nearly the same activity as the total extract confirming that lysoPC (or a co-eluting lipid) was a major antimigratory molecule in oxidized LDL. These studies demonstrate that lysoPC in oxidized LDL limit EC wound healing responses in vitro, and suggest a possible role for lysolipids in limiting endothelial regeneration after a denuding injury in vivo.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1996        PMID: 8675684      PMCID: PMC507366          DOI: 10.1172/JCI118728

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  70 in total

1.  High-density lipoprotein antagonizes the inhibitory effects of oxidized low-density lipoprotein and lysolecithin on soluble guanylyl cyclase.

Authors:  K Schmidt; P Klatt; W F Graier; G M Kostner; W R Kukovetz
Journal:  Biochem Biophys Res Commun       Date:  1992-01-15       Impact factor: 3.575

Review 2.  Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis.

Authors:  S Ylä-Herttuala
Journal:  Ann Med       Date:  1991       Impact factor: 4.709

3.  Scatter factor regulates vascular endothelial cell motility.

Authors:  E M Rosen; W Carley; I D Goldberg
Journal:  Cancer Invest       Date:  1990       Impact factor: 2.176

4.  Lysolecithin binding to human and squirrel monkey plasma and tissue components.

Authors:  O W Portman; D R Illingworth
Journal:  Biochim Biophys Acta       Date:  1973-10-17

5.  Metabolism of lysolecithin in vivo and in vitro with particular emphasis on the arterial wall.

Authors:  O W Portman; D R Illingworth
Journal:  Biochim Biophys Acta       Date:  1974-04-26

6.  Transport of lysolecithin by albumin in human and rat plasma.

Authors:  S Switzer; H A Eder
Journal:  J Lipid Res       Date:  1965-10       Impact factor: 5.922

7.  Acidic fibroblast growth factor promotes vascular repair.

Authors:  T D Bjornsson; M Dryjski; J Tluczek; R Mennie; J Ronan; T N Mellin; K A Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

8.  Effects of copper and histidine on oxidative modification of low density lipoprotein and its subsequent binding to collagen.

Authors:  N Kalant; S McCormick; M A Parniak
Journal:  Arterioscler Thromb       Date:  1991 Sep-Oct

9.  Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis.

Authors:  O W Portman; M Alexander
Journal:  J Lipid Res       Date:  1969-03       Impact factor: 5.922

10.  High performance liquid chromatographic separation and direct ultraviolet detection of phospholipids.

Authors:  W S Van Kessel; W M Hax; R A Demel; J De Gier
Journal:  Biochim Biophys Acta       Date:  1977-03-25
View more
  31 in total

1.  Factors determining heterogeneity in coronary collateral development: A clinical perspective.

Authors:  Pier D Lambiase; Michael S Marber
Journal:  Exp Clin Cardiol       Date:  2002

Review 2.  Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.

Authors:  Sanjiv Singh; Avtar Singh Gautam
Journal:  Curr Atheroscler Rep       Date:  2019-07-27       Impact factor: 5.113

3.  Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome.

Authors:  Makoto Kurano; Kuniyuki Kano; Tomotaka Dohi; Hirotaka Matsumoto; Koji Igarashi; Masako Nishikawa; Ryunosuke Ohkawa; Hitoshi Ikeda; Katsumi Miyauchi; Hiroyuki Daida; Junken Aoki; Yutaka Yatomi
Journal:  J Lipid Res       Date:  2016-12-22       Impact factor: 5.922

4.  A Lipidomics Approach to Identifying Key Lipid Species Involved in VEGF-Inhibitor Mediated Attenuation of Bleomycin-Induced Pulmonary Fibrosis.

Authors:  Yogesh M Kulkarni; Sucharita Dutta; Anand Krishnan V Iyer; Clayton A Wright; Vani Ramesh; Vivek Kaushik; Oliver John Semmes; Neelam Azad
Journal:  Proteomics Clin Appl       Date:  2018-01-19       Impact factor: 3.494

5.  Integration of TRPC6 and NADPH oxidase activation in lysophosphatidylcholine-induced TRPC5 externalization.

Authors:  Pinaki Chaudhuri; Michael A Rosenbaum; Lutz Birnbaumer; Linda M Graham
Journal:  Am J Physiol Cell Physiol       Date:  2017-08-23       Impact factor: 4.249

6.  P110α and P110δ catalytic subunits of PI3 kinase regulate lysophosphatidylcholine-induced TRPC6 externalization.

Authors:  Pinaki Chaudhuri; Andrew H Smith; Priya Putta; Linda M Graham; Michael A Rosenbaum
Journal:  Am J Physiol Cell Physiol       Date:  2021-02-24       Impact factor: 4.249

7.  Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma.

Authors:  Jian-Min Wu; Yan Xu; Nicholas J Skill; Hongmiao Sheng; Zhenwen Zhao; Menggang Yu; Romil Saxena; Mary A Maluccio
Journal:  Mol Cancer       Date:  2010-03-31       Impact factor: 27.401

8.  GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells.

Authors:  Alexander Bondarenko; Markus Waldeck-Weiermair; Shamim Naghdi; Michael Poteser; Roland Malli; Wolfgang F Graier
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

9.  Oxidized LDL activates fas-mediated endothelial cell apoptosis.

Authors:  M Sata; K Walsh
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

10.  Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.

Authors:  Lin Ma; Hitoshi Uchida; Jun Nagai; Makoto Inoue; Jerold Chun; Junken Aoki; Hiroshi Ueda
Journal:  Mol Pain       Date:  2009-11-13       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.